Clinical Genomics

Selected news for the healthcare topic - Clinical Genomics, collected since 10/2017. Recent stories appear in archynewsy.com and world-news-monitor.com. This healthcare topic shares news with COVID-19, Food and Drug Administration, Quest Diagnostics, Precision Medicine and dozens of others.

Please provide a valid email address.

Selected Headines

Date Headline (link) Source Relevant Snippet
2/8/2021 [ASAP] Tissue Lipidomic Alterations Induced by Prolonged Dexamethasone Treatment acs.org Tissue Lipidomic Alterations Induced by Prolonged Dexamethasone Treatment Adriana Zardini Buzatto Essa M. Sabi Essa M. Sabi Ahmed H. Mujamammi Ahmed H. Mujamammi Anas M. Abdel Rahman Anas M. Abdel Rahman Metabolomics Section, Clinical Genomics , Center for Genomics Medicine, King Faisal Specialist Hospital and Research Centre (KFSHRC), Zahrawi Street, Al Maather, Riyadh 11211, Saudi Arabia Department of Chemistry, Memorial University of Newfoundland, St. John’s, NL A1B 3X7, Canada Cite ...
2/4/2021 PierianDx Partners with the Belgian Society of Medical Oncology (BSMO) to Evaluate Potential of Comprehensive Genomic Profiling in Late-Stage Cancer Real-World Setting Across Belgium Yahoo News BALLETT Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patientsPierianDx, the global leader in clinical genomics knowledge, today announced a partnership with the Belgian Society of Medical Oncology (BSMO) to study the impact of comprehensive genomic profiling (CGP) on clinical outcomes of late-stage cancer patients. As part of the study, nine sites across Belgium ...
2/4/2021 PierianDx Partners with the Belgian Society of Medical Oncology (BSMO) to Evaluate Potential of Comprehensive Genomic Profiling in Late-Stage Cancer Real-World Setting Across Belgium Yahoo News BALLETT Study will measure the impact of comprehensive genomic profiling on access to, and uptake of, personalized medicines and on clinical outcomes for patientsPierianDx, the global leader in clinical genomics knowledge, today announced a partnership with the Belgian Society of Medical Oncology (BSMO) to study the impact of comprehensive genomic profiling (CGP) on clinical outcomes of late-stage cancer patients. As part of the study, nine sites across Belgium ...
2/3/2021 Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology enlightenbio.blog ... somatic cancer, a therapeutic area that has been identified as a key area of future focus by the Company owing to the significant scale of the oncology market coupled with the untapped potential of clinical genomics to impact patient care in the space.Gabriel was founded by Professor Andrew Biankin, Dr. Susanna Cooke and Dr. Philip Beer of the University of Glasgow. Between them, the founders have deep expertise in ...
1/24/2021 Global GI Stool Testing Market 2019 Analysis by Key Players: Clinical Genomics, Diasorin, Meridian Bioscience, Quidel nysenewstimes.com Market Analysis Global GI Stool Testing Market 2019 Analysis by Key Players: Clinical Genomics, Diasorin, Meridian Bioscience, Quidel david GI Stool Testing Market GI Stool Testing Market Growth GI Stool Testing Market Price GI Stool Testing Market Size and Share GI Stool Testing Market Trends Global GI Stool Testing Market 2019Magnifier Research has recently added a comprehensive research report titled Global GI Stool Testing Market Size, Status and Forecast ...
1/14/2021 Congenica Launches Patient Advocacy and Engagement Advisory Board Globe Newswire ... genetics and precision medicine will ensure that the patient perspective remains at the heart of Congenica’s strategy. Alongside this, the new board will serve to inform patients and clinicians on the role of clinical genomics in the diagnostic journey. Congenica’s digital technology enables the rapid analysis and interpretation of genomic data on a massive scale, performing multiple analyses on a patient’s DNA once it has been sampled ...
1/11/2021 Illumina (ILMN), Helix Partner to Develop Tracking Setup in U.S. - January 11, 2021 - Zacks.com Zacks ... footprint. This, in turn, is likely to significantly expand the country’s existing surveillance efforts to detect and characterize emerging variants of SARS-CoV-2.With the latest collaboration, Illumina aims to strengthen its Clinical Genomics business worldwide.Rationale Behind the Collaboration Illumina’s management believes that genomic surveillance is crucial in the fight against the pandemic. The company is partnering with Helix and CDC to provide accurate sequencing. Further ...
12/10/2020 They develop a technique to trace the origin of covid-19 in 4 hours archynewsy.com ... a new ‘unknown’ case of coronavirus is identified, every minute counts,” stressed the lead author of this study, Ira Deveson, head of the Genomic Technologies Group at UNSW’s Garvan Center for Clinical Genomics .This new technique consists of identifying the genetic variations that occur in covid-19 transmissions to establish the relationship between those who contracted the virus, while opening the possibility that a future the genomic ...
12/10/2020 Researchers develop rapid genomics strategy to trace coronavirus world-news-monitor.com ... and Kirby Institute to develop faster SARS-CoV-2 genome sequencing capabilities, potentially enhancing the ability of contact tracers to take rapid action to quarantine and monitor potential contacts. Garvan’s Kinghorn Centre for Clinical Genomics is the first facility in Australia to establish and apply this Nanopore technology for genomic surveillance of SARS-CoV-2.» read more Science: Coronavirus news... Latest Science: Coronavirus News ...
12/8/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets blogspot.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting ST. LOUIS-Wednesday 2 ](BUSINESS WIRE) -- PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer Panel. Adding ...
12/8/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets blogspot.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting ST. LOUIS-Wednesday 2 (BUSINESS WIRE) -- PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer Panel. Adding ...
12/8/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets blogspot.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting ST. LOUIS-Wednesday 2 ](BUSINESS WIRE) -- PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer Panel. Adding ...
12/8/2020 Balaji Srinivasan: The Man Who Called COVID coindesk.com ... became an angel investor and intellectual firebrand of the cryptocurrency community, Srinivasan had co-founded a genetic testing company that was eventually sold for $375 million. He had also written papers on microbial and clinical genomics and taught bioinformatics at Stanford. So even though his degrees were in electrical and chemical engineering, he knew a thing or two about biology.This article is part of CoinDesk's Most Influential 2020 – ...
12/8/2020 Balaji Srinivasan: The Man Who Called COVID Yahoo News ... became an angel investor and intellectual firebrand of the cryptocurrency community, Srinivasan had co-founded a genetic testing company that was eventually sold for $375 million. He had also written papers on microbial and clinical genomics and taught bioinformatics at Stanford. So even though his degrees were in electrical and chemical engineering, he knew a thing or two about biology. artwork, by Matt Kane Super Rare , with the sale proceeds ...
12/5/2020 Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study plos.org ... review & editing Affiliation Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, United Kingdom ⨯ Roles Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Writing – review & editing E-mail: Affiliation Section on Clinical Genomics and Experimental Therapeutics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States of America ...
12/4/2020 Küresel Kolorektal Kanser Tarama pazar? 2020 Boyut ve Pay, Bölgesel Talep, Gelecek Kapsam?, Zorluklar, Kilit Oyuncular, ?? Geli?tirme F?rsat? ve 2026’ye Tahmin haberradikal.com ... rsat? ve 2026’ye Tahmin 4 December 2020Yeni bir rapor olan Global Kolorektal Kanser Tarama pazar?, küresel Kolorektal Kanser Tarama Kolorektal Kanser Tarama sample/15701476Küresel Kolorektal Kanser Tarama Alere INC, Clinical Genomics , Beckman Coulter, Abbott, Exact Sciences Corp., Sysmex Corporation, Hemosure, Quidel Corporation, Eiken Chemical, Novigenix SA, Epigenomics AG, and others.Global Kolorektal Kanser Tarama Kolorektal Kanser Tarama covid19/15701476Global Kolorektal Kanser Tarama Test Tipine g ...
12/3/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets Wordpress.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reportingST. LOUIS-Wednesday 2 December 2020 [ AETOS Wire ](BUSINESS WIRE) — PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq for Illumina® Focus Panel, AmpliSeq for Illumina® Myeloid Panel and the TruSight Hereditary Cancer ...
12/3/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets Wordpress.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reportingST. LOUIS-Wednesday 2 December 2020 [ AETOS Wire ](BUSINESS WIRE) — PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq for Illumina® Focus Panel, AmpliSeq for Illumina® Myeloid Panel and the TruSight Hereditary Cancer ...
12/3/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets blogspot.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reportingST. LOUIS- -- PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight™ Hereditary Cancer Panel. Adding these panels expands the ...
12/3/2020 PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets blogspot.com Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reportingST. LOUIS-Wednesday 2 December 2020 [ AETOS Wire ](BUSINESS WIRE) -- PierianDx, the leading clinical genomics informatics company, today announced an expanded partnership with Illumina to enable PierianDx genomic reporting solutions for use with AmpliSeq™ for Illumina® Focus Panel, AmpliSeq™ for Illumina® Myeloid Panel and the TruSight℠...